Axonics Past Earnings Performance
Past criteria checks 0/6
Axonics's earnings have been declining at an average annual rate of -7.8%, while the Medical Equipment industry saw earnings growing at 12.3% annually. Revenues have been growing at an average rate of 58.4% per year.
Key information
-7.8%
Earnings growth rate
39.9%
EPS growth rate
| Medical Equipment Industry Growth | 12.9% |
| Revenue growth rate | 58.4% |
| Return on equity | -5.4% |
| Net Margin | -10.1% |
| Last Earnings Update | 30 Jun 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Axonics makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 23 | 320 | -32 | 213 | 33 |
| 31 Mar 23 | 296 | -46 | 208 | 31 |
| 31 Dec 22 | 274 | -60 | 196 | 34 |
| 30 Sep 22 | 241 | -76 | 184 | 36 |
| 30 Jun 22 | 217 | -77 | 168 | 37 |
| 31 Mar 22 | 194 | -80 | 151 | 39 |
| 31 Dec 21 | 180 | -80 | 136 | 37 |
| 30 Sep 21 | 162 | -76 | 121 | 35 |
| 30 Jun 21 | 150 | -68 | 109 | 34 |
| 31 Mar 21 | 120 | -63 | 95 | 32 |
| 31 Dec 20 | 112 | -55 | 92 | 29 |
| 30 Sep 20 | 87 | -66 | 89 | 27 |
| 30 Jun 20 | 53 | -82 | 87 | 24 |
| 31 Mar 20 | 39 | -81 | 82 | 23 |
| 31 Dec 19 | 14 | -80 | 68 | 20 |
| 30 Sep 19 | 4 | -67 | 51 | 19 |
| 30 Jun 19 | 3 | -49 | 34 | 18 |
| 31 Mar 19 | 2 | -39 | 21 | 19 |
| 31 Dec 18 | 1 | -32 | 13 | 19 |
| 30 Sep 18 | 0 | -28 | 10 | 18 |
| 30 Jun 18 | 0 | -25 | 7 | 17 |
| 31 Mar 18 | 0 | -20 | 6 | 14 |
| 31 Dec 17 | 0 | -18 | 6 | 12 |
Quality Earnings: AXNX * is currently unprofitable.
Growing Profit Margin: AXNX * is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AXNX * is unprofitable, and losses have increased over the past 5 years at a rate of 7.8% per year.
Accelerating Growth: Unable to compare AXNX *'s earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AXNX * is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-3%).
Return on Equity
High ROE: AXNX * has a negative Return on Equity (-5.36%), as it is currently unprofitable.